# Aripiprazole for the Treatment of Mania in Children and Adolescents With Bipolar Disorder

> **NCT00181779** · PHASE4 · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 20 (—)

## Conditions studied

- Bipolar Disorder
- Mania

## Interventions

- **DRUG:** aripiprazole (Abilify)

## Key facts

- **NCT ID:** NCT00181779
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-02
- **Primary completion:** 2006-12
- **Final completion:** 2006-12
- **Target enrollment:** 20 (—)
- **Last updated:** 2013-10-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00181779

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00181779, "Aripiprazole for the Treatment of Mania in Children and Adolescents With Bipolar Disorder". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00181779. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*